Innovations In Clinical Neuroscience

MAR-APR 2018

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 5 of 55

20 February 2018 Unresolved Problems in Neuroscience Drug Development: Point/Counterpoint (Kalali) Topic 1: Should we give up on targeting amyloid for neurodegenerative diseases? (Butler) Topic 2: Does increasing the sample size provide greater precision for detecting treatment effects? (Sachs) Working Group Sessions Welcome Reception 21 February 2018 Use of Regulatory Databases as Exemplars for Improving RCT Efficiency and Guidance Development: Can the Model Be Extended? (Farchione, Martynowicz) Methodological Challenges Related to Rare and Orphan Disease Drug Development (Busner, Dunn, Anand) Poster Session/Reception 22 February 2018 Joint Session with The Michael J. Fox Foundation Innovative Approaches for Slowing Disease Progression in Parkinson's Disease (Budur, Turkoz, Shoulson, Frasier) SAVE THE DATE 2018 Autumn Meeting 15-16 October 2018 – Marina del Rey, California

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - MAR-APR 2018